EP1314424A1 — Seamless soft capsule preparations containing dihydrobenzofuran derivatives
Assigned to Chugai Pharmaceutical Co Ltd · Expires 2003-05-28 · 23y expired
What this patent protects
The invention provides seamless soft capsule formulations characterized by comprising dihydrobenzofuran derivatives represented by general formula (1): wherein R 1 represents hydrogen or an acyl group, R 2 represents hydrogen or a lower alkyl group and R 3 and R 4 may be th…
USPTO Abstract
The invention provides seamless soft capsule formulations characterized by comprising dihydrobenzofuran derivatives represented by general formula (1): wherein R 1 represents hydrogen or an acyl group, R 2 represents hydrogen or a lower alkyl group and R 3 and R 4 may be the same or different and each represents one selected from the group consisting of hydrogen, optionally substituted alkyl groups, optionally substituted alkenyl groups, optionally substituted alkynyl groups, optionally substituted aryl groups and optionally substituted arylalkyl groups. The seamless soft capsule formulations provide excellent stability by adequately preventing degradation by oxidation and the like.
Drugs covered by this patent
- Vascepa (ICOSAPENT ETHYL) · Amarin Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.